| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
17,771,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
2,200 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.3 - $2.3 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile OptimizeRx is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. Connecting healthcare providers in the U.S. and of patients through a proprietary point-of-care network, the OptimizeRx digital health platform helps patients start and stay on medications. Co.'s principal solutions and applications include: Financial Messaging; Brand and Therapeutic Support Messaging; Brand Support; Patient engagement; Evidence-Based Physician Engagement; and Therapy Initiation Workflow.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
321,408 |
321,408 |
321,408 |
| Total Buy Value |
$0 |
$2,443,761 |
$2,443,761 |
$2,443,761 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
4,000 |
| Total Sell Value |
$0 |
$0 |
$0 |
$60,751 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Klema Cathy |
Director |
– • – |
2025-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
9,868 |
21,620 |
|
- |
|
| Lang James Paul |
Director |
– • – |
2025-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
9,868 |
399,320 |
|
- |
|
| Wasson Gregory D |
Director |
– • – |
2025-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
9,868 |
57,183 |
|
- |
|
| Vos Ellen Oconnor |
Director |
– • – |
2025-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
9,868 |
72,642 |
|
- |
|
| Spangler Patrick D |
Director |
– • – |
2025-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
9,868 |
55,335 |
|
- |
|
| Greco Theresa |
Chief Commercial Officer |
• – – |
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,483 |
60,356 |
|
- |
|
| Silvestro Stephen L |
Chief Commercial Officer |
• – – |
2025-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
46,948 |
168,262 |
|
- |
|
| Lang James Paul |
Director |
– • – |
2025-03-14 |
4 |
B |
$7.60 |
$2,443,761 |
D/D |
321,408 |
389,452 |
2.39 |
- |
|
| Silvestro Stephen L |
Chief Commercial Officer |
• – – |
2025-03-01 |
4 |
D |
$5.18 |
$2,963 |
D/D |
(572) |
121,314 |
|
- |
|
| Silvestro Stephen L |
Chief Commercial Officer |
• – – |
2025-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,928 |
121,886 |
|
- |
|
| Odence-Ford Marion |
Chief Legal Officer & CHRO |
• – – |
2025-03-01 |
4 |
D |
$5.18 |
$1,388 |
D/D |
(268) |
70,276 |
|
- |
|
| Odence-Ford Marion |
Chief Legal Officer & CHRO |
• – – |
2025-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
771 |
70,544 |
|
- |
|
| Stelmakh Edward |
CFO/COO |
• – – |
2025-02-15 |
4 |
D |
$6.64 |
$14,316 |
D/D |
(2,156) |
95,139 |
|
- |
|
| Silvestro Stephen L |
Chief Commercial Officer |
• – – |
2025-02-15 |
4 |
D |
$6.64 |
$15,259 |
D/D |
(2,298) |
119,958 |
|
- |
|
| Odence-Ford Marion |
Chief Legal Officer & CHRO |
• – – |
2025-02-15 |
4 |
D |
$6.64 |
$9,821 |
D/D |
(1,479) |
69,773 |
|
- |
|
| Besch Doug |
Chief Product Officer |
• – – |
2025-02-15 |
4 |
D |
$6.64 |
$9,203 |
D/D |
(1,386) |
51,605 |
|
- |
|
| Febbo William J |
CEO |
• • – |
2025-02-14 |
4 |
D |
$6.64 |
$2,663 |
D/D |
(401) |
600,852 |
|
- |
|
| Odence-Ford Marion |
General Counsel and CCO |
• – – |
2025-02-11 |
4 |
D |
$5.60 |
$7,762 |
D/D |
(1,386) |
71,252 |
|
- |
|
| Odence-Ford Marion |
General Counsel and CCO |
• – – |
2025-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,000 |
72,638 |
|
- |
|
| Klema Cathy |
Director |
– • – |
2025-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,109 |
11,752 |
|
- |
|
| Odence-Ford Marion |
General Counsel and CCO |
• – – |
2024-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
41,408 |
68,638 |
|
- |
|
| Besch Doug |
Chief Product Officer |
• – – |
2024-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
41,408 |
52,991 |
|
- |
|
| Stelmakh Edward |
CFO/COO |
• – – |
2024-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
41,408 |
97,295 |
|
- |
|
| Silvestro Stephen L |
Chief Commercial Officer |
• – – |
2024-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
41,408 |
122,256 |
|
- |
|
| Greco Theresa |
Chief Commercial Officer |
• – – |
2024-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
15,528 |
50,873 |
|
- |
|
370 Records found
|
|
Page 1 of 15 |
|
|
